The United States will launch the COVID-19 vaccine against COVID-19 's XBB variant this autumn.

[the United States will launch the COVID-19 vaccine against the XBB variant of COVID-19 this autumn] according to the Wall Street Journal, consultants from the US Food and Drug Administration (FDA) said that the COVID-19 vaccine vaccinated this fall should target the latest variety of O'Micron, which is currently popular in the United States. Advisers voted 21-0 on Thursday that FDA should update the current COVID-19 vaccine to target a single XBB substrain. Scientists attending the meeting said that by targeting one of the variants of XBB, these vaccines should also protect against other variants of the virus.